This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Bencze, J., Seo, W., Hye, A., Aarsland, D., & Hortobagyi, T. (2020). Dementia with Lewy bodies - a clinicopathological update. Free Neuropathology, 1(7), 1 -12. https://doi.org/10.1789/freeneuropathology-2020-2613Bencze,J.Seo,W.Hye,A.Aarsland,D.Hortobagyi,T.(2020).Dementia with Lewy bodies - a clinicopathological update.Free Neuropathology,1(7),1-12. https://doi.org/10.1789/freeneuropathology-2020-2613Search in Google Scholar
Chin, K., Teodorczuk, A., & Watson, R. (2019). Dementia with Lewy bodies: Challenges in the diagnosis and management. Australian & New Zealand Journal of Psychiatry, 53(4), 291 -303. https://doi.org/10.1177/0004867419835029Chin,K.Teodorczuk,A.Watson,R.(2019).Dementia with Lewy bodies: Challenges in the diagnosis and management.Australian & New Zealand Journal of Psychiatry,53(4),291-303. https://doi.org/10.1177/000486741983502910.1177/000486741983502930848660Search in Google Scholar
Coon, E., Cutsforth-Gregory, J., & Benarroch, E. (2018). Neuropathology of autonomic dysfunction in synucleinopathies. Movement Disorders, 33(3), 349-358. https://doi.org/10.1002/mds.27186Coon,E.Cutsforth-Gregory,J.Benarroch,E.(2018).Neuropathology of autonomic dysfunction in synucleinopathies.Movement Disorders,33(3),349-358. https://doi.org/10.1002/mds.2718610.1002/mds.2718629297596Search in Google Scholar
Creese, B., Ballard, C., Aarsland, D., Londos, E., Sharp, S., & Jones, E. (2014). Determining the Association of the 5HTTLPR Polymorphism with Delusions and Hallucinations in Lewy Body Dementias. The American Journal of Geriatric Psychiatry, 22(6), 580-586. https://doi.org/10.1016/j.jagp.2012.11.001Creese,B.Ballard,C.Aarsland,D.Londos,E.Sharp,S.Jones,E.(2014).Determining the Association of the 5HTTLPR Polymorphism with Delusions and Hallucinations in Lewy Body Dementias.The American Journal of Geriatric Psychiatry,22(6),580-586. https://doi.org/10.1016/j.jagp.2012.11.00110.1016/j.jagp.2012.11.00123582751Search in Google Scholar
Cromarty, R., Elder, G., Graziadio, S., Baker, M., Bonanni, L., & Onofrj, M. et al. (2016). Neurophysiological biomarkers for Lewy body dementias. Clinical Neurophysiology, 127(1), 349-359. https://doi.org/10.1016/j.clinph.2015.06.020Cromarty,R.Elder,G.Graziadio,S.Baker,M.Bonanni,L.Onofrj,M. et al.(2016).Neurophysiological biomarkers for Lewy body dementias.Clinical Neurophysiology,127(1),349-359. https://doi.org/10.1016/j.clinph.2015.06.02010.1016/j.clinph.2015.06.020472750626183755Search in Google Scholar
Cuervo, A. (2004). Impaired Degradation of Mutant -Synuclein by Chaperone-Mediated Autophagy. Science, 305 (5688), 1292-1295. https://doi.org/10.1126/science.1101738Cuervo,A.(2004).Impaired Degradation of Mutant -Synuclein by Chaperone-Mediated Autophagy.Science,305(5688),1292-1295. https://doi.org/10.1126/science.110173810.1126/science.110173815333840Search in Google Scholar
Donaghy, P., & McKeith, I. (2014). The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis. Alzheimer’s Research & Therapy, 6(4), 46. https://doi.org/10.1186/alzrt274Donaghy,P.McKeith,I.(2014).The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis.Alzheimer’s Research & Therapy,6(4),46. https://doi.org/10.1186/alzrt27410.1186/alzrt274425538725484925Search in Google Scholar
Dugger, B., Adler, C., Shill, H., Caviness, J., Jacobson, S., Driver-Dunckley, E., & Beach, T. (2014). Concomitant pathologies among a spectrum of parkinsonian disorders. Parkinsonism & Related Disorders, 20(5), 525-529. https://doi.org/10.1016/j.parkreldis.2014.02.012Dugger,B.Adler,C.Shill,H.Caviness,J.Jacobson,S.Driver-Dunckley,E.Beach,T.(2014).Concomitant pathologies among a spectrum of parkinsonian disorders.Parkinsonism & Related Disorders,20(5),525-529. https://doi.org/10.1016/j.parkreldis.2014.02.01210.1016/j.parkreldis.2014.02.012402841824637124Search in Google Scholar
Fujishiro, H., Iseki, E., Nakamura, S., Kasanuki, K., Chiba, Y., & Ota, K. et al. (2013). Dementia with Lewy bodies: early diagnostic challenges. Psychogeriatrics, 13(2), 128-138. https://doi.org/10.1111/psyg.12005Fujishiro,H.Iseki,E.Nakamura,S.Kasanuki,K.Chiba,Y.Ota,K. et al.(2013).Dementia with Lewy bodies: early diagnostic challenges.Psychogeriatrics,13(2),128-138. https://doi.org/10.1111/psyg.1200510.1111/psyg.1200523909972Search in Google Scholar
Fukui, T., Oowan, Y., Yamazaki, T., & Kinno, R. (2013). Prevalence and Clinical Implication of Microbleeds in Dementia with Lewy Bodies in Comparison with Microbleeds in Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders Extra, 3(1), 148-160. https://doi.org/10.1159/000351423Fukui,T.Oowan,Y.Yamazaki,T.Kinno,R.(2013).Prevalence and Clinical Implication of Microbleeds in Dementia with Lewy Bodies in Comparison with Microbleeds in Alzheimer’s Disease.Dementia and Geriatric Cognitive Disorders Extra,3(1),148-160. https://doi.org/10.1159/00035142310.1159/000351423367063123741227Search in Google Scholar
Huber, M., Beyer, L., Prix, C., Schönecker, S., Palleis, C., & Rauchmann, B. et al. (2019). Metabolic Correlates of Dopaminergic Loss in Dementia with Lewy Bodies. Movement Disorders, 35(4), 595-605. https://doi.org/10.1002/mds.27945Huber,M.Beyer,L.Prix,C.Schönecker,S.Palleis,C.Rauchmann,B. et al.(2019).Metabolic Correlates of Dopaminergic Loss in Dementia with Lewy Bodies.Movement Disorders,35(4),595-605. https://doi.org/10.1002/mds.2794510.1002/mds.2794531840326Search in Google Scholar
Jellinger, K., & Korczyn, A. (2018). Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?. BMC Medicine, 16(1). https://doi.org/10.1186/s12916-018-1016-8Jellinger,K.Korczyn,A.(2018).Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?.BMC Medicine,16(1). https://doi.org/10.1186/s12916-018-1016-810.1186/s12916-018-1016-8584083129510692Search in Google Scholar
Kane, J., Surendranathan, A., Bentley, A., Barker, S., Taylor, J., & Thomas, A. et al. (2018). Clinical prevalence of Lewy body dementia. Alzheimer’s Research & Therapy, 10(1). https://doi.org/10.1186/s13195-018-0350-6Kane,J.Surendranathan,A.Bentley,A.Barker,S.Taylor,J.Thomas,A. et al.(2018).Clinical prevalence of Lewy body dementia.Alzheimer’s Research & Therapy,10(1). https://doi.org/10.1186/s13195-018-0350-610.1186/s13195-018-0350-6581520229448953Search in Google Scholar
Klein, J., Eggers, C., Kalbe, E., Weisenbach, S., Hohmann, C., & Vollmar, S. et al. (2010). Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo. Neurology, 74(11), 885-892. https://doi.org/10.1212/wnl.0b013e3181d55f61Klein,J.Eggers,C.Kalbe,E.Weisenbach,S.Hohmann,C.Vollmar,S. et al.(2010).Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo.Neurology,74(11),885-892. https://doi.org/10.1212/wnl.0b013e3181d55f6110.1212/WNL.0b013e3181d55f6120181924Search in Google Scholar
Kon, T., Tomiyama, M., & Wakabayashi, K. (2019). Neuropathology of Lewy body disease: Clinicopathological crosstalk between typical and atypical cases. Neuropathology, 40(1), 30 -39. https://doi.org/10.1111/neup.12597Kon,T.Tomiyama,M.Wakabayashi,K.(2019).Neuropathology of Lewy body disease: Clinicopathological crosstalk between typical and atypical cases.Neuropathology,40(1),30-39. https://doi.org/10.1111/neup.1259710.1111/neup.1259731498507Search in Google Scholar
Lee, G., Cummings, J., Decourt, B., Leverenz, J., & Sabbagh, M. (2019). Clinical drug development for dementia with Lewy bodies: past and present. Expert Opinion on Investigational Drugs, 28(11), 951-965. https://doi.org/10.1080/13543784.2019.168 1398Lee,G.Cummings,J.Decourt,B.Leverenz,J.Sabbagh,M.(2019).Clinical drug development for dementia with Lewy bodies: past and present.Expert Opinion on Investigational Drugs,28(11),951-965. https://doi.org/10.1080/13543784.2019.168139810.1080/13543784.2019.1681398682315931614096Search in Google Scholar
Lim, X., Yeo, J., Green, A., & Pal, S. (2013). The diagnostic utility of cerebrospinal fluid alpha-synuclein analysis in dementia with Lewy bodies —/INS; a systematic review and meta-analysis. Journal of The Neurological Sciences, 333, e296-e297. https://doi.org/10.1016/j.jns.2013.07.1117Lim,X.Yeo,J.Green,A.Pal,S.(2013).The diagnostic utility of cerebrospinal fluid alpha-synuclein analysis in dementia with Lewy bodies —/INS; a systematic review and meta-analysis.Journal of The Neurological Sciences,333,e296-e297. https://doi.org/10.1016/j.jns.2013.07.111710.1016/j.jns.2013.07.1117Search in Google Scholar
Londos, E., Hansson, O., Rosén, I., & Englund, E. (2019). Extreme sleep pattern in Lewy body dementia: a hypothalamic matter?. BMJ Case Reports, 12(3), e228177. https://doi.org/10.1136/bcr-2018-228177Londos,E.Hansson,O.Rosén,I.Englund,E.(2019).Extreme sleep pattern in Lewy body dementia: a hypothalamic matter?.BMJ Case Reports,12(3),e228177. https://doi.org/10.1136/bcr-2018-22817710.1136/bcr-2018-228177642426130852516Search in Google Scholar
Matar, E., Ehgoetz Martens, K., Halliday, G., & Lewis, S. (2019). Clinical features of Lewy body dementia: insights into diagnosis and pathophysiology. Journal of Neurology, 267(2), 380-389. https://doi.org/10.1007/s00415-019-09583-8Matar,E.Ehgoetz Martens,K.Halliday,G.Lewis,S.(2019).Clinical features of Lewy body dementia: insights into diagnosis and pathophysiology.Journal of Neurology,267(2),380-389. https://doi.org/10.1007/s00415-019-09583-810.1007/s00415-019-09583-831650254Search in Google Scholar
Matar, E., Shine, J., Halliday, G., & Lewis, S. (2019). Cognitive fluctuations in Lewy body dementia: towards a pathophysiological framework. Brain, 143(1), 31-46. https://doi.org/10.1093/brain/awz311Matar,E.Shine,J.Halliday,G.Lewis,S.(2019).Cognitive fluctuations in Lewy body dementia: towards a pathophysiological framework.Brain,143(1),31-46. https://doi.org/10.1093/brain/awz31110.1093/brain/awz31131612904Search in Google Scholar
McCleery, J., Morgan, S., Bradley, K., Noel-Storr, A., Ansorge, O., & Hyde, C. (2015). Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd010633 .pub2McCleery,J.Morgan,S.Bradley,K.Noel-Storr,A.Ansorge,O.Hyde,C.(2015).Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies.Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd010633.pub210.1002/14651858.CD010633Search in Google Scholar
McKeith, I., Boeve, B., Dickson, D., Halliday, G., Taylor, J., & Weintraub, D. et al. (2017). Diagnosis and management of dementia with Lewy bodies. Neurology, 89(1), 88-100. https://doi.org/10.1212/wnl.0000000000004058McKeith,I.Boeve,B.Dickson,D.Halliday,G.Taylor,J.Weintraub,D. et al.(2017).Diagnosis and management of dementia with Lewy bodies.Neurology,89(1),88-100. https://doi.org/10.1212/wnl.000000000000405810.1212/WNL.0000000000004058Search in Google Scholar
Mollenhauer, B., & Schlossmacher, M. (2010). CSF synuclein: adding to the biomarker footprint of dementia with Lewy bodies. Journal of Neurology, Neurosurgery & Psychiatry, 81(6), 590-591. https://doi.org/10.1136/jnnp.2010.206391Mollenhauer,B.Schlossmacher,M.(2010).CSF synuclein: adding to the biomarker footprint of dementia with Lewy bodies.Journal of Neurology, Neurosurgery & Psychiatry,81(6),590-591. https://doi.org/10.1136/jnnp.2010.20639110.1136/jnnp.2010.206391Search in Google Scholar
Nedelska, Z., Ferman, T., Boeve, B., Przybelski, S., Lesnick, T., & Murray, M. et al. (2015). Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies. Neurobiology of Aging, 36(1), 452-461. https://doi.org/10.1016/j.neurobiolaging.2014.07.005Nedelska,Z.Ferman,T.Boeve,B.Przybelski,S.Lesnick,T.Murray,M. et al.(2015).Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies.Neurobiology of Aging,36(1),452-461. https://doi.org/10.1016/j.neurobiolaging.2014.07.00510.1016/j.neurobiolaging.2014.07.005Search in Google Scholar
Olanow, C., Perl, D., DeMartino, G., & McNaught, K. (2004). Lewy-body formation is an aggresome-related process: a hypothesis. The Lancet Neurology, 3(8), 496-503. https://doi.org/10.1016/s1474-4422(04) 00827-0Olanow,C.Perl,D.DeMartino,G.McNaught,K.(2004).Lewy-body formation is an aggresome-related process: a hypothesis.The Lancet Neurology,3(8),496-503. https://doi.org/10.1016/s1474-4422(04)00827-010.1016/S1474-4422(04)00827-0Search in Google Scholar
Schumacher, J., Peraza, L., Firbank, M., Thomas, A., Kaiser, M., & Gallagher, P. et al. (2019). Dysfunctional brain dynamics and their origin in Lewy body dementia. Brain, 142(6), 1767-1782. https://doi.org/10.1093/brain/awz069Schumacher,J.Peraza,L.Firbank,M.Thomas,A.Kaiser,M.Gallagher,P. et al.(2019).Dysfunctional brain dynamics and their origin in Lewy body dementia.Brain,142(6),1767-1782. https://doi.org/10.1093/brain/awz06910.1093/brain/awz069Search in Google Scholar
Spillantini, M., & Goedert, M. (2006). The α-Synucleinopathies: Parkinson’s Disease, Dementia with Lewy Bodies, and Multiple System Atrophy. Annals of The New York Academy of Sciences, 920(1), 16-27. https://doi.org/10.1111/j.1749-6632.2000.tb06900.xSpillantini,M.Goedert,M.(2006).The α-Synucleinopathies: Parkinson’s Disease, Dementia with Lewy Bodies, and Multiple System Atrophy.Annals of The New York Academy of Sciences,920(1),16-27. https://doi.org/10.1111/j.1749-6632.2000.tb06900.x10.1111/j.1749-6632.2000.tb06900.xSearch in Google Scholar
Surendranathan, A., Kane, J., Bentley, A., Barker, S., McNally, R., & Bamford, C. et al. (2021). Introduction of an assessment toolkit associated with increased rate of DLB diagnosis. Alzheimer’s Research & Therapy, 13(1). https://doi.org/10.1186/s13195-021-00786-8Surendranathan,A.Kane,J.Bentley,A.Barker,S.McNally,R.Bamford,C. et al.(2021).Introduction of an assessment toolkit associated with increased rate of DLB diagnosis.Alzheimer’s Research & Therapy,13(1). https://doi.org/10.1186/s13195-021-00786-810.1186/s13195-021-00786-8Search in Google Scholar
Surendranathan, A., Rowe, J., & O’Brien, J. (2015). Neuroinflammation in Lewy body dementia. Parkinsonism & Related Disorders, 21(12), 1398-1406. https://doi.org/10.1016/j.parkreldis.2015.10.009Surendranathan,A.Rowe,J.O’Brien,J.(2015).Neuroinflammation in Lewy body dementia.Parkinsonism & Related Disorders,21(12),1398-1406. https://doi.org/10.1016/j.parkreldis.2015.10.00910.1016/j.parkreldis.2015.10.009Search in Google Scholar
Taylor, J., McKeith, I., Burn, D., Boeve, B., Weintraub, D., & Bamford, C. et al. (2020). New evidence on the management of Lewy body dementia. The Lancet Neurology, 19(2), 157-169. https://doi.org/10.1016/s1474-4422(19)30153-xTaylor,J.McKeith,I.Burn,D.Boeve,B.Weintraub,D.Bamford,C. et al.(2020).New evidence on the management of Lewy body dementia.The Lancet Neurology,19(2),157-169. https://doi.org/10.1016/s1474-4422(19)30153-x10.1016/S1474-4422(19)30153-XSearch in Google Scholar
Thomas, A., Taylor, J., McKeith, I., Bamford, C., Burn, D., Allan, L., & O’Brien, J. (2018). Revision of assessment toolkits for improving the diagnosis of Lewy body dementia: The DIAMOND Lewy study. International Journal of Geriatric Psychiatry, 33(10), 1293-1304. https://doi.org/10.1002/gps.4948Thomas,A.Taylor,J.McKeith,I.Bamford,C.Burn,D.Allan,L.O’Brien,J.(2018).Revision of assessment toolkits for improving the diagnosis of Lewy body dementia: The DIAMOND Lewy study.International Journal of Geriatric Psychiatry,33(10),1293-1304. https://doi.org/10.1002/gps.494810.1002/gps.4948622100930091150Search in Google Scholar
Thomas, A., Taylor, J., McKeith, I., Bamford, C., Burn, D., Allan, L., & O’Brien, J. (2016). Development of assessment toolkits for improving the diagnosis of the Lewy body dementias: feasibility study within the DIAMOND Lewy study. International Journal of Geriatric Psychiatry, 32(12), 1280-1304. https://doi.org/10.1002/gps.4609Thomas,A.Taylor,J.McKeith,I.Bamford,C.Burn,D.Allan,L.O’Brien,J.(2016).Development of assessment toolkits for improving the diagnosis of the Lewy body dementias: feasibility study within the DIAMOND Lewy study.International Journal of Geriatric Psychiatry,32(12),1280-1304. https://doi.org/10.1002/gps.460910.1002/gps.4609Search in Google Scholar
Valera, E., & Masliah, E. (2015). Combination therapies: The next logical Step for the treatment of synucleinopathies?. Movement Disorders, 31(2), 225-234. https://doi.org/10.1002/mds.26428Valera,E.Masliah,E.(2015).Combination therapies: The next logical Step for the treatment of synucleinopathies?.Movement Disorders,31(2),225-234. https://doi.org/10.1002/mds.2642810.1002/mds.26428Search in Google Scholar
van Dellen, E., de Waal, H., van der Flier, W., Lemstra, A., Slooter, A., & Smits, L. et al. (2015). Loss of EEGNetwork Efficiency Is Related to Cognitive Impairment in Dementia with Lewy Bodies. Movement Disorders, 30(13), 1785-1793. https://doi.org/10.1002/mds.26309van Dellen,E.de Waal,H.van der Flier,W.Lemstra,A.Slooter,A.Smits,L. et al.(2015).Loss of EEGNetwork Efficiency Is Related to Cognitive Impairment in Dementia with Lewy Bodies.Movement Disorders,30(13),1785-1793. https://doi.org/10.1002/mds.2630910.1002/mds.26309Search in Google Scholar
Vann Jones, S., & O’Brien, J. (2013). The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. Psychological Medicine, 44 (4), 673-683. https://doi.org/10.1017/s0033291713000494Vann Jones,S.O’Brien,J.(2013).The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies.Psychological Medicine,44(4),673-683. https://doi.org/10.1017/s003329171300049410.1017/S0033291713000494Search in Google Scholar
Wakabayashi, K., Mori, F., Tanji, K., Orimo, S., & Takahashi, H. (2010). Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain. Acta Neuropathologica, 120(1), 1-12. https://doi.org/10.1007/s00401-010-0706-xWakabayashi,K.Mori,F.Tanji,K.Orimo,S.Takahashi,H.(2010).Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain.Acta Neuropathologica,120(1),1-12. https://doi.org/10.1007/s00401-010-0706-x10.1007/s00401-010-0706-xSearch in Google Scholar
Walker, Z., Possin, K., Boeve, B., & Aarsland, D. (2015). Lewy body dementias. The Lancet, 386(10004), 1683-1697. https://doi.org/10.1016/s0140-6736(15)00462-6Walker,Z.Possin,K.Boeve,B.Aarsland,D.(2015).Lewy body dementias.The Lancet,386(10004),1683-1697. https://doi.org/10.1016/s0140-6736(15)00462-610.1016/S0140-6736(15)00462-6Search in Google Scholar
Yamada, M., Komatsu, J., Nakamura, K., Sakai, K., Samuraki-Yokohama, M., Nakajima, K., & Yoshita, M. (2020). Diagnostic Criteria for Dementia with Lewy Bodies: Updates and Future Directions. Journal of Movement Disorders, 13(1), 1-10. https://doi.org/10.14802/jmd.19052Yamada,M.Komatsu,J.Nakamura,K.Sakai,K.Samuraki-Yokohama,M.Nakajima,K.Yoshita,M.(2020).Diagnostic Criteria for Dementia with Lewy Bodies: Updates and Future Directions.Journal of Movement Disorders,13(1),1-10. https://doi.org/10.14802/jmd.1905210.14802/jmd.19052698752931694357Search in Google Scholar
Yousaf, T., Dervenoulas, G., Valkimadi, P., & Politis, M. (2018). Neuroimaging in Lewy body dementia. Journal of Neurology, 266(1), 1-26. https://doi.org/10.1007/s00415-018-8892-xYousaf,T.Dervenoulas,G.Valkimadi,P.Politis,M.(2018).Neuroimaging in Lewy body dementia.Journal of Neurology,266(1),1-26. https://doi.org/10.1007/s00415-018-8892-x10.1007/s00415-018-8892-x634288329761296Search in Google Scholar
Zweig, Y., & Galvin, J. (2014). Lewy body dementia: the impact on patients and caregivers. Alzheimer’s Research & Therapy, 6(2), 21. https://doi.org/10.1186/alzrt251Zweig,Y.Galvin,J.(2014).Lewy body dementia: the impact on patients and caregivers.Alzheimer’s Research & Therapy,6(2),21. https://doi.org/10.1186/alzrt25110.1186/alzrt251405493725031635Search in Google Scholar
